<--- Back to Details
First PageDocument Content
Oncogenes / Melanoma / Biotechnology / Biomarker / Colorectal cancer / Selumetinib / Sodium-iodide symporter / Medicine / Oncology / BRAF
Date: 2014-11-19 02:15:21
Oncogenes
Melanoma
Biotechnology
Biomarker
Colorectal cancer
Selumetinib
Sodium-iodide symporter
Medicine
Oncology
BRAF

BRAF V600E Mutation Detection Howard Robin, M.D. Revised[removed]HIGHLIGHTS

Add to Reading List

Source URL: molecularresponse.com

Download Document from Source Website

File Size: 218,13 KB

Share Document on Facebook

Similar Documents

Large ElectronPositron Collider

Biotechnology, BS "DBEFNJD.BQ  5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT

DocID: 1xTqy - View Document

PDF Document

DocID: 1wroO - View Document

Building A Better Mousetrap: Patenting Biotechnology In The European Community

DocID: 1vr7C - View Document

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

DocID: 1vq6b - View Document

Biotechnology Consultation Agency Response Letter BNF

DocID: 1vpUZ - View Document